Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

Hin Chu, Bingjie Hu, Xiner Huang, Yue Chai, Yixin Wang, Huiping Shuai, Dong Yang, Yuxin Hou, Xi Zhang, Terrence Tsz‐Tai Yuen, Jian‐Piao Cai, Jinxia Zhang, Jie Zhou, Shuofeng Yuan, Kelvin Kai‐Wang To, Ivy Hau-Yee Chan, Ko‐Yung Sit, Cc Foo, Yhi Wong, Ada Tsui‐Lin Ng, Tan To Cheung, Simon Law, Wing-Kuk Au, Kin‐Hang Kok, Jasper Fuk‐Woo Chan, Kwok‐Yung YuenResearch 2020 · DOI

This study, conducted by researchers at the University of Hong Kong during the early stages of the COVID-19 pandemic, identifies the specific molecular "keys" that allow SARS-CoV-2 to infect human lung tissue so much more efficiently than its predecessor, SARS-CoV. By examining host cell factors like heparan sulfate and sialic acids alongside viral features like the furin cleavage site, the authors provide a roadmap for understanding the high transmissibility of the virus.

TL;DR

Researchers identified that SARS-CoV-2 uses heparan sulfate as a critical "landing pad" for infection and has evolved to bypass sialic acid-mediated defenses that normally restrict other coronaviruses. Furthermore, a specific "furin-like" insertion in the virus's spike protein is the essential driver for its ability to replicate in the lungs, explaining its high pathogenicity compared to related viruses.

What Problem Does This Paper Address?

Early in the pandemic, a major mystery was why SARS-CoV-2 spread so much faster than the 2003 SARS-CoV, despite both using the same primary entry receptor, ACE2. Curiously, ACE2 levels in the human respiratory tract are actually quite low. This suggested that the virus must be using additional "attachment factors" or co-receptors to find and enter cells.

The authors set out to identify these missing determinants—both on the host cell surface and within the viral genome—that facilitate efficient infection of the human lung versus other organs like the intestines.

Methods

The team employed a multi-disciplinary approach combining molecular biology with rare physiological models:

  • Ex Vivo Tissue Explants: Instead of relying solely on immortalized cell lines, the researchers used live human lung and intestinal tissues obtained from surgeries. This provides a much more accurate "real-world" look at how the virus behaves in human organs.
  • CRISPR/Cas9 Gene Editing: They created knockout cell lines (specifically targeting the SLC35A1 gene) to study the role of sialic acid transporters.
  • Reverse Genetics: The authors generated a mutant version of SARS-CoV-2 (S1/S2mut) that lacked the 10-amino acid furin cleavage site to isolate its specific function.
  • Biochemical Inhibition: They used heparinases (enzymes that chew up heparan sulfate) and neuraminidases (which remove sialic acids) to see how the virus's ability to attach and replicate changed when these surface molecules were missing.

Datasets

The study primarily generated its own experimental data rather than using large external datasets. Key biological materials included:

  • Viral Strains: SARS-CoV-2 (HKU-001a), SARS-CoV (GZ50), and MERS-CoV (EMC/2012).
  • Cell Lines: A panel of seven human and animal cell lines, including Calu3 (lung), Caco2 (intestine), and VeroE6 (monkey kidney).
  • Human Samples: Ex vivo lung and intestine tissues from patients at Queen Mary Hospital, Hong Kong.

Key Insights and Ideas

  • Heparan Sulfate as a "Velcro" Factor: The virus uses heparan sulfate (a sugar molecule on cell surfaces) as an essential attachment factor. Think of it as a "landing pad" that catches the virus and holds it close to the cell until it can find an ACE2 receptor to initiate entry.
  • Bypassing the Sialic Acid Barrier: In a surprising twist, the researchers found that cell-surface sialic acids actually restrict the original SARS-CoV. However, SARS-CoV-2 has evolved the ability to largely overcome this restriction, allowing it to infect cells that its predecessor could not.
  • The Furin Site is the "Lung Key": SARS-CoV-2 has a unique four-amino acid insertion (RRAR) that creates a furin cleavage site. The study proved this site is mandatory for replication in the lung but unnecessary in the intestine. This is because the intestine is rich in another enzyme (TMPRSS2) that can do the job, whereas the lung relies more heavily on the virus bringing its own "pre-cut" spike protein via furin.

Key Results

  • Attachment: Blocking heparan sulfate reduced SARS-CoV-2 attachment by 48–55% and reduced overall replication in lung cells by 73%.
  • Sialic Acid Restriction: Removing sialic acids increased SARS-CoV replication by a staggering 492%, but only marginally affected SARS-CoV-2, proving the newer virus is much better at ignoring this host defense.
  • Lung Tropism: The mutant virus lacking the furin site replicated 25.2-fold worse in lung cells (Calu3) compared to the wild-type virus.
  • Organ Specificity: In ex vivo human lung tissue, the wild-type virus was 2.3 to 3.2 times more efficient at replicating than the furin-site mutant. In contrast, both viruses performed similarly in intestinal tissue.

Limitations and Future Work

The authors acknowledge that while they identified these factors as "essential," they are part of a complex web of interactions. A primary limitation is that the study was conducted using early 2020 strains; as the virus has mutated into variants like Delta and Omicron, the relative importance of these factors (especially the furin site) has continued to evolve.

Future work suggested by the paper includes exploring heparan sulfate mimetics (like modified heparin) as potential therapeutic interventions to "clog" the virus's landing pads before it can infect the lungs.

Summary updated

Abstract

Abstract SARS-CoV-2 has affected over 9 million patients with more than 460,000 deaths in about 6 months. Understanding the factors that contribute to efficient SARS-CoV-2 infection of human cells, which are not previously reported, may provide insights on SARS-CoV-2 transmissibility and pathogenesis, and reveal targets of intervention. Here, we reported key host and viral determinants that were essential for efficient SARS-CoV-2 infection in the human lung. First, we identified heparan sulfate as an important attachment factor for SARS-CoV-2 infection. Second, we demonstrated that while cell surface sialic acids significantly restricted SARS-CoV infection, SARS-CoV-2 could largely overcome sialic acid-mediated restriction in both human lung epithelial cells and ex vivo human lung tissue explants. Third, we demonstrated that the inserted furin-like cleavage site in SARS-CoV-2 spike was required for efficient virus replication in human lung but not intestine tissues. Overall, these findings contributed to our understanding on efficient SARS-CoV-2 infection of human lungs.
BibTeX
@inproceedings{chu2020host,
  author = {Hin Chu and Bingjie Hu and Xiner Huang and Yue Chai and Yixin Wang and Huiping Shuai and Dong Yang and Yuxin Hou and Xi Zhang and Terrence Tsz‐Tai Yuen and Jian‐Piao Cai and Jinxia Zhang and Jie Zhou and Shuofeng Yuan and Kelvin Kai‐Wang To and Ivy Hau-Yee Chan and Ko‐Yung Sit and CC Foo and Yhi Wong and Ada Tsui‐Lin Ng and Tan To Cheung and Simon Law and Wing-Kuk Au and Kin‐Hang Kok and Jasper Fuk‐Woo Chan and Kwok‐Yung Yuen},
  title = {{Host and viral determinants for efficient SARS-CoV-2 infection of the human lung}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-40123/v1},
}

Loading related content...

Figure